The Patent Office Journal 31/05/2013 12028
(12) PATENT APPLICATION PUBLICATION (21) Application No.2472/CHENP/2012 A
(19) INDIA
(22) Date of filing of Application :16/03/2012 (43) Publication Date : 31/05/2013
(54) Title of the invention : GLYCINE COMPOUND
(51) International classification :C07C237/04
(31) Priority Document No :2009-214991
(32) Priority Date :16/09/2009
(33) Name of priority country :Japan
(86) International Application No
Filing Date
:PCT/JP2010/065918
:15/09/2010
(87) International Publication No :WO 2011/034078A1
(61) Patent of Addition to Application
Number
Filing Date
:NA
:NA
(62) Divisional to Application Number
Filing Date
:NA
:NA
(71)Name of Applicant :
1)ASTELLAS PHARMA INC.
Address of Applicant :3-11, NIHONBASHI-HONCHO 2-
CHOME, CHUO-KU, TOKYO-103-8411 Japan
(72)Name of Inventor :
1)YOSHIHARA, KOUSEI
2)SUZUKI, DAISUKE
3)YAMAKI, SUSUMU
4)KOGA, YUJI
5)SEKI, NORIO
6)FUJIYASU, JIRO
(57) Abstract :
The present invention provides a compound which is useful as an active ingredient of a pharmaceutical composition, in particular,
a pharmaceutical composition for preventing and/or treating VAP-1-related diseases. [Means for Solution] The present inventors
have conducted intensive studies on a compound having a VAP-1 inhibitory activity, and as a result, they have found that a
compound of the present invention or a salt thereof exhibits an excellent VAP-1 inhibitory activity and is useful for preventing
and/or treating VAP-1-related diseases, in particular, diabetic nephropathy or diabetic macular edema, thereby completing the
present invention. The present invention further relates to a pharmaceutical composition, in particular, a pharmaceutical
composition for preventing and/or treating VAP-1-related diseases, which comprises the compound of the present invention or a
salt thereof, and an excipient.
No. of Pages : 255 No. of Claims : 25
